Skip to main content
. Author manuscript; available in PMC: 2014 Jul 3.
Published in final edited form as: Bone Marrow Transplant. 2010 Jun 28;46(4):510–515. doi: 10.1038/bmt.2010.160

Table 2.

Adverse events secondary to topotecan, melphalan and CY regimen

Toxicity grade 1 Toxicity grade 2 Toxicity grade 3 Toxicity grade 4
Cardiovascular Edema: 1 Edema: 3
Venous thrombus: 1
Arrhythmia: 1
Mild heart failure: 1
Severe heart failure: 1
General Fever: 1
Lethargy: 6
0 0 0
Gastrointestinal Diarrhea: 22
Nausea: 25
Vomiting: 11
Mucositis/stomatitis: 8
Diarrhea: 3
Nausea: 10
Mucositis/stomatitis: 18
GI Hemorrhage: 1
Vomiting: 1
Mucositis/stomatitis: 13
Infection 3 3 2 0
Metabolic Hypokalemia: 1 Hypokalemia: 1 Hypokalemia: 2
Hypomagnesemia: 1
0
Hematological Leukopenia: 60
Thrombocytopenia: 60